The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV ...

The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease, kidney failure and ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Its weight-loss drug policy would fall to Trump's pick for health secretary, Robert F Kennedy Jr, and Mehmet Oz, Trump's ...

Frozen’s Josh Gad shared insight into his weight loss journey after losing 40 pounds with the help of medication.

W hether in Reddit comments or during real talk among my friends, I’ve been noticing more discussions about the role of GLP-1 ...

The newer GLP-1 medications may qualify as such. The GLP-1s include semaglutide (Ozempic, Wegovy) and the combination of GLP-1/GIP drug tirzepatide (Mounjaro, Zepbound). Studies are evaluating their ...

Back to Healio Preliminary evidence indicates that glucagon-like peptide-1 receptor agonists like Ozempic and similar weight-loss drugs may also help treat substance use disorders. The “exciting ...

The market for GLP-1 medications, driven by blockbuster drugs like Novo Nordisk's Ozempic and Wegovy, is transforming how obesity and weight management are addressed. These medications have shown ...